# Fecal Microbiota Transfer to Improve Diabetes Control Post-bariatric Surgery

> **NCT06192693** · PHASE3 · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 54 (estimated)

## Conditions studied

- Bariatric Surgery
- Type 2 Diabetes

## Interventions

- **DRUG:** Capsulized fecal microbiota transfer containing the healthy feces + stool dilution solution
- **DRUG:** Capsulized placebo transfer containing dilution solution

## Key facts

- **NCT ID:** NCT06192693
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-21
- **Primary completion:** 2029-02
- **Final completion:** 2029-02
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2025-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06192693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06192693, "Fecal Microbiota Transfer to Improve Diabetes Control Post-bariatric Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06192693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*